83 related articles for article (PubMed ID: 2254228)
1. Loss of ciprofloxacin's second killing action in Escherichia coli that have developed 4-quinolone resistance during therapy.
Lewin CS; Blakemore P; Drabu YJ; Smith JT
J Antimicrob Chemother; 1990 Oct; 26(4):594-6. PubMed ID: 2254228
[No Abstract] [Full Text] [Related]
2. Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Malik M; Hussain S; Drlica K
Antimicrob Agents Chemother; 2007 Jan; 51(1):28-34. PubMed ID: 17043118
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
Zemelman R; Vejar C; Bello H; Domínguez M; González G
Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
[TBL] [Abstract][Full Text] [Related]
4. Quinolone resistance from a transferable plasmid.
Martínez-Martínez L; Pascual A; Jacoby GA
Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of and resistance to ciprofloxacin.
Hooper DC; Wolfson JS; Ng EY; Swartz MN
Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
[TBL] [Abstract][Full Text] [Related]
6. Characterization of quinolone resistance in Escherichia coli strains of animal origin from Italy.
Forcella C; Alessiani A; Perilli M; Zilli K; Di Giannatale E; Amicosante G
J Chemother; 2010 Jun; 22(3):165-8. PubMed ID: 20566420
[TBL] [Abstract][Full Text] [Related]
7. The mode of action of 4-quinolones and possible mechanisms of resistance.
Smith JT
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Antibiotic Efflux Machinery in Glutathione-Mediated Decreased Ciprofloxacin Activity in Escherichia coli.
Goswami M; Subramanian M; Kumar R; Jass J; Jawali N
Antimicrob Agents Chemother; 2016 Jul; 60(7):4369-74. PubMed ID: 27139480
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
[TBL] [Abstract][Full Text] [Related]
10. Detection of plasmid-mediated qnr genes among the quinolone-resistant Escherichia coli isolates in Iran.
Firoozeh F; Zibaei M; Soleimani-Asl Y
J Infect Dev Ctries; 2014 Jul; 8(7):818-22. PubMed ID: 25022290
[TBL] [Abstract][Full Text] [Related]
11. Role of the outer membrane for quinolone resistance in enterobacteria.
Dechène M; Leying H; Cullmann W
Chemotherapy; 1990; 36(1):13-23. PubMed ID: 2106416
[TBL] [Abstract][Full Text] [Related]
12. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
[TBL] [Abstract][Full Text] [Related]
13. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Jan; 34(1):19-22. PubMed ID: 1703579
[TBL] [Abstract][Full Text] [Related]
14. Effect of macarbomycin on transfer of R factor among strains of Escherichia coli in vitro.
Fukuyasu T; Shimizu T; Terakado N
Natl Inst Anim Health Q (Tokyo); 1972; 12(4):201-6. PubMed ID: 4574595
[No Abstract] [Full Text] [Related]
15. The response of Escherichia coli to ciprofloxacin and norfloxacin.
Elliott TS; Shelton A; Greenwood D
J Med Microbiol; 1987 Feb; 23(1):83-8. PubMed ID: 3546699
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Piddock LJ; Hall MC; Walters RN
J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
[TBL] [Abstract][Full Text] [Related]
18. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
19. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.
Drews SJ; Poutanen SM; Mazzulli T; McGeer AJ; Sarabia A; Pong-Porter S; Rzayev Y; Willey B; Green K; Low DE
J Clin Microbiol; 2005 Aug; 43(8):4218-20. PubMed ID: 16081983
[TBL] [Abstract][Full Text] [Related]
20. [Interaction between nalidixic acid and some antibacterial substances].
Dominici A; Perini C
Antibiotica; 1967 Sep; 5(3):212-23. PubMed ID: 4890810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
